Indolylarylsulfones carrying a heterocyclic tail as very potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.
暂无分享,去创建一个
E. Novellino | A. Coluccia | A. Brancale | C. Zamperini | E. Crespan | G. Maga | M. Botta | R. Silvestri | G. La Regina | D. Schols | R. Badia | J. Esté | V. Limongelli | R. Cirilli | R. Ferretti | Eva Riveira-Muñoz | Sveva Pelliccia | Valeria Famiglini | Bruno Agostino | E. Riveira-Muñoz
[1] E. Novellino,et al. New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors. , 2014, European journal of medicinal chemistry.
[2] Mar Alvarez,et al. Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection. , 2014, Antiviral research.
[3] J. Vanderleyden,et al. The Lantibiotic Peptide Labyrinthopeptin A1 Demonstrates Broad Anti-HIV and Anti-HSV Activity with Potential for Microbicidal Applications , 2013, PloS one.
[4] L. Menéndez-Arias. Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments. , 2013, Antiviral research.
[5] Liping Wang,et al. Rational design of potent non-nucleoside inhibitors of HIV-1 reverse transcriptase. , 2012, Journal of medicinal chemistry.
[6] E. Novellino,et al. New nitrogen containing substituents at the indole-2-carboxamide yield high potent and broad spectrum indolylarylsulfone HIV-1 non-nucleoside reverse transcriptase inhibitors. , 2012, Journal of medicinal chemistry.
[7] B. Clotet,et al. Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1. , 2011, Antiviral research.
[8] E. Novellino,et al. Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at the indole-2-carboxamide , 2011 .
[9] F. Maldarelli,et al. Clinical Management of HIV Drug Resistance , 2011, Viruses.
[10] E. Novellino,et al. Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors: new cyclic substituents at indole-2-carboxamide. , 2011, Journal of medicinal chemistry.
[11] A. Coluccia,et al. Looking for an Active Conformation of the Future HIV Type-1 Non-Nucleoside Reverse Transcriptase Inhibitors , 2010, Antiviral chemistry & chemotherapy.
[12] A. Zolopa,et al. Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance. , 2010, Current opinion in investigational drugs.
[13] W. Sherman,et al. Probing the α‐Helical Structural Stability of Stapled p53 Peptides: Molecular Dynamics Simulations and Analysis , 2010, Chemical biology & drug design.
[14] B. Walker,et al. Immunology and the elusive AIDS vaccine , 2010, Nature.
[15] E. Novellino,et al. Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and coxsackie B4 virus. , 2009, Journal of medicinal chemistry.
[16] G. McGaughey,et al. Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs). , 2008, Bioorganic & medicinal chemistry letters.
[17] Thomas Stützle,et al. PLANTS: Application of Ant Colony Optimization to Structure-Based Drug Design , 2006, ANTS Workshop.
[18] A. Bergamini,et al. Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide. , 2006, Journal of medicinal chemistry.
[19] U Helena Danielson,et al. Interaction kinetic characterization of HIV-1 reverse transcriptase non-nucleoside inhibitor resistance. , 2006, Journal of medicinal chemistry.
[20] E. De Clercq,et al. First synthesis and evaluation of the inhibitory effects of aza analogues of TSAO on HIV-1 replication. , 2005, Journal of medicinal chemistry.
[21] A. Coluccia,et al. Docking and 3-D QSAR studies on indolyl aryl sulfones. Binding mode exploration at the HIV-1 reverse transcriptase non-nucleoside binding site and design of highly active N-(2-hydroxyethyl)carboxamide and N-(2-hydroxyethyl)carbohydrazide derivatives. , 2005, Journal of medicinal chemistry.
[22] R. Silvestri,et al. Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations. , 2004, Journal of medicinal chemistry.
[23] P P Chamberlain,et al. Crystal structures of HIV-1 reverse transcriptases mutated at codons 100, 106 and 108 and mechanisms of resistance to non-nucleoside inhibitors. , 2004, Journal of molecular biology.
[24] Silvio Massa,et al. Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies. , 2003, Journal of medicinal chemistry.
[25] D I Stuart,et al. Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors. , 2001, Journal of molecular biology.
[26] M. Machida,et al. High Throughput Prediction of Oral Absorption: Improvement of the Composition of the Lipid Solution Used in Parallel Artificial Membrane Permeation Assay , 2001, Journal of biomolecular screening.
[27] A. D. Clark,et al. The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance. , 2001, Journal of molecular biology.
[28] R. Friesner,et al. Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides† , 2001 .
[29] B. Faller,et al. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. , 2001, Journal of medicinal chemistry.
[30] D I Stuart,et al. Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase. , 2000, Structure.
[31] U Hübscher,et al. Resistance to nevirapine of HIV-1 reverse transcriptase mutants: loss of stabilizing interactions and thermodynamic or steric barriers are induced by different single amino acid substitutions. , 1997, Journal of molecular biology.
[32] W. L. Jorgensen,et al. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .
[33] J. Janin,et al. Analytical approximation to the accessible surface area of proteins. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[34] D. Tarbell,et al. A Study of the Schönberg Rearrangement of Diaryl Thioncarbonates to Diaryl Thiolcarbonates1 , 1955 .
[35] T. Cihlar,et al. Current status and challenges of antiretroviral research and therapy. , 2010, Antiviral research.
[36] T. Hawkins. Understanding and managing the adverse effects of antiretroviral therapy. , 2010, Antiviral research.
[37] P. Hamel,et al. A New Synthesis of 3-Arylthioindoles , 1988 .
[38] F. Korte,et al. Thermolyse von O,O-dialkyl-S-aryl-thiophosphorsäureestern , 1965 .